Global Fibromyalgia treatments market is anticipated to grow at a significant CAGR in the forthcoming period. Fibromyalgia is known as a chronic muscular pain and tenderness. Most people with fibromyalgia also suffer from additional symptoms from fatigue, stiffness, sleep disturbances, cognitive memory problems and symptoms of anxiety and depression. Causes of fibromyalgia can be different for different personalities and is very unlikely that there are several types of genes that can be prevalent in people to develop fibromyalgia and can trigger fibromyalgia.
Driving factors responsible for the growth of fibromyalgia treatments market includes rise in geriatric population coupled with drug availability to lessen the symptoms of fibromyalgia. On the other hand, fibromyalgia is a complicated disease and hard to diagnose since most of the symptoms are allied with other diseases as well, which in turn lowers the diagnosis rate of patients suffering from fibromyalgia, thus hampering the growth of fibromyalgia treatments Industry.
Segmentation based on type, the fibromyalgia treatments market includes antidepressants, anticonvulsants, muscle relaxants, analgesics, pain relievers, anti-seizure drugs and therapy. Segmentation based on application, the fibromyalgia treatments industry includes research centers, hospitals and clinics and laboratories. Segmentation based on distribution channels, the fibromyalgia treatments market includes drug stores, hospitals pharmacies, retail pharmacies and online pharmacies.
Geographically, fibromyalgia treatments industry spans North America, South America, Europe, Asia-Pacifica, Middle-East and Africa. North America enjoys a significant position owing to presence of multinational players, rise in research & development investments coupled with rise in healthcare expenditure. APAC market is also anticipated to grow at a higher CAGR in the forthcoming period due to rise in geriatric population and drug availability of fibromyalgia.
The key players in the fibromyalgia treatments industry include Leiner Health Products, LNK International, A&S Pharmaceutical Corporation, Bayer Healthcare, Sanofi, Endo International, Johnson & Johnson, Purdue Pharma, Teva Pharmaceutical Industries Ltd, Eli Lilly and Company, Merck and Pfizer Inc.
This report studies the global Fibromyalgia Treatments market, analyzes and researches the Fibromyalgia Treatments development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• A&S Pharmaceutical Corp
• Leiner Health Products
• LNK International
• Pharmaceutical Formulations
• Bayer Healthcare
• Endo International
• Johnson & Johnson
• Purdue Pharma
• Teva Pharmaceutical Industries Ltd
• Eli Lilly and Company
• Pfizer Inc
Market segment by Regions/Countries, this report covers
• United States
• Southeast Asia
Market segment by Type, Fibromyalgia Treatments can be split into
• Pain Relievers
• Anti-Seizure Drugs
Market segment by Application, Fibromyalgia Treatments can be split into
• Hospitals and Clinics
• Research Centers
Research Support Specialist, USA